Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 12Recruiting 2Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Genitourinary 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 47Triple Negative Breast Neoplasms 10Colorectal Neoplasms 6Prostatic Neoplasms 5Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Stomach Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vaginitis 1Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Osteosarcoma 1Neuroendocrine Tumors 1Multiple Myeloma 1Margins of Excision 1Lymphedema 1Liver Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Gastrointestinal Stromal Tumors × Breast × Clear all
NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡